Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Iowa Tech Report.
Press releases published on October 13, 2025
Theolytics to Present Ongoing Phase I/IIa OCTOPOD-IV Trial of THEO-260 in Ovarian Cancer at ESMO 2025
THEO-260 is an oncolytic immunotherapy developed for effective targeting of cancer cells and cancer-associated fibroblasts, whilst inducing immune activation in stromal rich tumours UK clinical trial recruitment is on track, and additional international …
Vertex und Kintsugi präsentieren KI-gestützte Lösung zur Steuerautomatisierung:
Kintsugi powered by Vertex KING OF PRUSSIA, PA, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ: VERX) („Vertex“ oder das „Unternehmen“), ein weltweit führender Anbieter von Lösungen für indirekte Steuern, präsentiert die Markteinführung von Kintsugi …
HUTCHMED Highlights FRUSICA-2 Registration Trial Data to be Presented at the 2025 ESMO Congress
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Oct. 13, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) announces results from the FRUSICA-2 registration clinical trial of the fruquintinib and sintilimab …
Market Alert: AlphaTON Capital Continues in Growth Mode and Purchases an additional 300,000 TON
Dover, DE, Oct. 12, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp. (Nasdaq: ATON) stated that during the market conditions of the past week, AlphaTON Capital is still expanding its TON Treasury, purchasing an additional 300,000 TON off the open market …
Qualigen Therapeutics Announces the Official Launch of C10 Cryptocurrency Asset Treasury (DAT) Purchases: Why Is This Pullback the Golden Moment CXC10 Has Been Waiting For?
Carlsbad, CA, Oct. 12, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced the official launch of C10 Cryptocurrency Asset Treasury (DAT) purchases: Why is this pullback the golden moment CXC10 has been …